MOORE TIMOTHY L. 4

What Happened Timothy L. Moore, a director of BioLife Solutions, was granted 8,170 restricted shares (transaction code A) on 2026-02-24. No cash price was reported for the award (N/A). The grant was made under the BioLife Solutions 2023 Performance Incentive Plan and is a compensation award rather than an open-market purchase.

Key Details

• Transaction date: 2026-02-24; filing date (Form 4): 2026-02-26 (appears timely).
• Price: N/A (restricted stock award).
• Shares awarded: 8,170 restricted shares.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The restricted stock "was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026."
• Transaction type code: A = Award/Grant.

Context Restricted stock awards are a common form of director and executive compensation and typically vest over time, limiting immediate sale. Because this was a granted award (not a purchase or sale), it signals compensation or retention rather than an outright market bet by the insider.